Carmen Núñez Lagos Previous PostCEA Italian Chapter Conference “Arbitration in biotechnology and pharmaceutical cases: issues and ethics, Salus ante omnia”, Turin, 7 October 2022Next PostPublication of the IBA Small Value Claims in Investment Arbitration, drafter, November 2022
